Acrivon Therapeutics, Inc.

ACRV · Nasdaq · SIC 2834: Pharmaceutical Preparations
62
SEC Filings

Business Summary

4 Item 1A. Risk Factors 32 Item 1B. Unresolved Staff Comments 79 Item 1C. Cybersecurity 79 Item 2. Properties 80 Item 3. Legal Proceedings 80 Item 4. Mine Safety Disclosures 80 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 81 Item 6. Reserved 81 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 82 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 94 Item 8. F...

Next Earnings

Q2 FY2026 — expected 2026-09-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionACRVdiscussed_in_filing Cybersecurity
topic_mentionACRVdiscussed_in_filing Cybersecurity
topic_mentionACRVdiscussed_in_filing Cybersecurity
topic_mentionACRVdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001193125-26-115123EDGAR96K words
2025-03-272024-12-310000950170-25-046056EDGAR—
2024-03-282023-12-310000950170-24-037618EDGAR—
2023-03-282022-12-310000950170-23-010331EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001193125-25-280215EDGAR24K words
2025-08-132025-06-300000950170-25-108054EDGAR—
2025-05-142025-03-310000950170-25-071427EDGAR—
2024-11-132024-09-300000950170-24-125929EDGAR—
2024-08-132024-06-300000950170-24-095760EDGAR—
2024-05-142024-03-310000950170-24-059084EDGAR—
2023-11-092023-09-300000950170-23-061553EDGAR—
2023-08-112023-06-300000950170-23-041593EDGAR—
2023-05-092023-03-310000950170-23-019157EDGAR—
2022-12-152022-09-300000950170-22-026622EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-190001193125-26-115139EDGAR3K words
2026-03-020001193125-26-085516EDGAR—
2026-02-270001193125-26-079500EDGAR—
2026-01-080001193125-26-007077EDGAR—
2026-01-080001193125-26-007007EDGAR—
2025-11-130001193125-25-280172EDGAR—
2025-09-050001193125-25-197250EDGAR—
2025-08-130001193125-25-179834EDGAR—
2025-06-130000950170-25-086246EDGAR—
2025-05-140000950170-25-071385EDGAR—

62 total filings indexed. 38 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001781174
TickerACRV
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 902394cb8ff4e4846659bdb5a7f25c40c73c0c81267f352b9b03159c2c5107a7
parent: 95006a5164e40b9ce9cffccd4a82c79dae13d52b63f733e590ca78c8c91d245f
content hash: a7a12248000f739b63aa968d7f162d8f29ac4d2b05f4ccefa6e965534224b977
signed: 2026-04-13T04:43:27.234Z
sources: 14 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf